3
Announcements
Trials
Browse
Landscape
Status
Completed
63
Recruiting
49
Terminated
28
Active not recruiting
19
Unknown
8
Withdrawn
3
Not yet recruiting
3
Suspended
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
2
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Ovarian Neoplasms
13
Uterine Cervical Neoplasms
7
Endometrial Neoplasms
6
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Vulvar Neoplasms
3
Prostatic Neoplasms
3
Peritoneal Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Neuroendocrine
2
Vulvar Diseases
1
Uterine Neoplasms
1
Tissue Adhesions
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Ovarian Cysts
1
Osteosarcoma
1
Obesity
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Squamous Cell Carcinoma of Head and Neck
×
Gynecologic
×
Clear all
NCT03253575
2019-04-08
ANCERS-2
Mitra RxDx, Inc.
Suspended
800 enrolled